...
机译:表皮生长因子受体酪氨酸激酶抑制剂对肺癌患者的毒性曲线:系统审查与网络荟萃分析
Guangzhou Med Univ Dept Thorac Surg &
Oncol Natl Clin Res Ctr Resp Dis State Key Lab Resp Dis;
Guangzhou Med Univ Dept Thorac Surg &
Oncol Natl Clin Res Ctr Resp Dis State Key Lab Resp Dis;
Guangzhou Med Univ Dept Thorac Surg &
Oncol Natl Clin Res Ctr Resp Dis State Key Lab Resp Dis;
Guangzhou Med Univ Dept Thorac Surg &
Oncol Natl Clin Res Ctr Resp Dis State Key Lab Resp Dis;
Guangzhou Med Univ Dept Thorac Surg &
Oncol Natl Clin Res Ctr Resp Dis State Key Lab Resp Dis;
Guangzhou Med Univ Dept Thorac Surg &
Oncol Natl Clin Res Ctr Resp Dis State Key Lab Resp Dis;
Guangzhou Med Univ Dept Thorac Surg &
Oncol Natl Clin Res Ctr Resp Dis State Key Lab Resp Dis;
Guangzhou Med Univ Dept Thorac Surg &
Oncol Natl Clin Res Ctr Resp Dis State Key Lab Resp Dis;
Guangzhou Med Univ Dept Thorac Surg &
Oncol Natl Clin Res Ctr Resp Dis State Key Lab Resp Dis;
Guangzhou Med Univ Dept Thorac Surg &
Oncol Natl Clin Res Ctr Resp Dis State Key Lab Resp Dis;
Guangzhou Med Univ Dept Thorac Surg &
Oncol Natl Clin Res Ctr Resp Dis State Key Lab Resp Dis;
Guangzhou Med Univ Dept Thorac Surg &
Oncol Natl Clin Res Ctr Resp Dis State Key Lab Resp Dis;
Guangzhou Med Univ Dept Thorac Surg &
Oncol Natl Clin Res Ctr Resp Dis State Key Lab Resp Dis;
Sun Yat Sen Univ Dept Med Oncol Collaborat Innovat Ctr Canc Med State Key Lab Oncol South China;
Guangzhou Med Univ Dept Resp Med Natl Clin Res Ctr Resp Dis State Key Lab Resp Dis Affiliated;
Guangzhou Med Univ Dept Thorac Surg &
Oncol Natl Clin Res Ctr Resp Dis State Key Lab Resp Dis;
Guangzhou Med Univ Dept Thorac Surg &
Oncol Natl Clin Res Ctr Resp Dis State Key Lab Resp Dis;
Guangzhou Med Univ Dept Thorac Surg &
Oncol Natl Clin Res Ctr Resp Dis State Key Lab Resp Dis;
Toxicity; Adverse event; EGFR; Lung cancer; Network meta-analysis;
机译:佐剂表皮生长因子受体酪氨酸激酶抑制剂(TKIS)在切除的非小细胞肺癌(NSCLC)中的系统审查和荟萃分析
机译:非小细胞肺癌患者表皮生长因子受体酪氨酸激酶抑制剂的肝毒性:网络元分析
机译:表皮生长因子受体 - 酪氨酸激酶抑制剂治疗后期非小细胞肺癌患者预后对重生预后的影响:系统评价
机译:喹唑啉衍生物作为表皮生长因子受体 - 酪氨酸激酶(EGFR-TK)抑制剂的QSAR研究
机译:表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物:随机对照试验的系统评价。
机译:表皮生长因子受体酪氨酸激酶抑制剂对表皮生长因子受体基因突变阳性肺癌患者的毒性谱
机译:148P中性粒细胞与酪氨酸激酶抑制剂处理表皮生长因子受体 - 突变体非小细胞肺癌的预后因素:系统评价和荟萃分析
机译:Egf受体单克隆抗体和化学疗法/ Cyrotoxic剂与酪氨酸激酶生长因子受体信号级联抑制剂之间协同相互作用的表征